Decision Diagnostics Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DECN research report →
Companywww.decisiondiagnostics.co
Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services.
- CEO
- Keith Berman
- IPO
- 2002
- Employees
- 6
- HQ
- Westlake Village, CA, US
Price Chart
Valuation
- Market Cap
- $35.45K
- P/E
- -0.00
- P/S
- 0.02
- P/B
- 0.06
- EV/EBITDA
- -1.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 25.18%
- Op Margin
- -106.68%
- Net Margin
- -1499.05%
- ROE
- -10388.57%
- ROIC
- -57.78%
Growth & Income
- Revenue
- $1.98M · -16.82%
- Net Income
- $-29,668,622 · -847.18%
- EPS
- $-0.11 · -428.85%
- Op Income
- $-2,111,432
- FCF YoY
- -14.13%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.05
- Avg Volume
- 1.10M
Get TickerSpark's AI analysis on DECN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DECN Coverage
We haven't published any research on DECN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DECN Report →